Literature DB >> 22594967

Relationship between vitamin D deficiency and nondipper hypertension.

Mehmet Demir1, Tufan Günay, Gökhan Özmen, Mehmet Melek.   

Abstract

Nondipper hypertension is associated with increased cardiovascular morbidity and mortality. Vitamin D deficiency is associated with cardiovascular diseases such as coronary artery disease, heart failure, and hypertension. Vitamin D deficiency activates the renin-angiotensin-aldosterone system, which affects the cardiovascular system. For this reason, a relationship between vitamin D deficiency and nondipper hypertension could be suggested. In this study, we compared 25-OH vitamin D levels between dipper and nondipper hypertensive patients. The study included 80 hypertensive patients and they were divided into two groups: 50 dipper patients (29 male, mean age 51.5 ± 8 years) and 30 nondipper patients (17 male, mean age 50.6 ± 5.4 years). All the patients were subjected to transthoracic echocardiography and ambulatory 24-hour blood pressure monitoring. In addition to routine tests, 25-OH vitamin D and parathormone (PTH) levels were analyzed. All the patients received antihypertensive drug therapy for at least 3 months prior to the evaluations. 25-OH vitamin D and PTH levels were compared between the two groups. No statistically significant difference was found between the two groups in terms of basic characteristics. The average PTH level of hypertensive dipper patients was lower than that of nondipper patients (65.3 ± 14.2 vs. 96.9 ± 30.8 pg/mL, P < .001). The average 25-OH vitamin D level of hypertensive dipper patients was higher than that of nondipper patients (21.9 ± 7.4 vs. 12.8 ± 5.9 ng/mL, P = .001). The left ventricular mass and left ventricular mass index were lower in the dipper patients than in the nondipper patients (186.5 ± 62.1 vs. 246.3 ± 85.3 g, P = .022; and 111.6 ± 21.2 vs.147 ± 25.7 g/m(2), P < .001, respectively). Other conventional echocardiographic parameters were similar between the two groups. Daytime systolic and diastolic blood pressure measurements were similar between dippers and nondippers, but there was a significant difference between the two groups with regard to nighttime measurements (nighttime systolic 118.5 ± 5.8 vs.130.2 ± 9.6 mm Hg, P < .001; and nighttime diastolic 69.3 ± 4.8 vs.78.1 ± 7.2 mm Hg, P < .001, respectively). Our results suggest that vitamin D deficiency has a positive correlation with blood pressure and vitamin D deficiency could be related to nondipper hypertension. The measurement of vitamin D may be used to indicate increased risk of hypertension-related adverse cardiovascular events.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22594967     DOI: 10.3109/10641963.2012.689045

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  5 in total

1.  Correlation between serum parathyroid hormone levels and coronary artery calcification in patients without renal failure.

Authors:  Gang-Yong Wu; Bai-Da Xu; Ting Wu; Xiao-Ying Wang; Tian-Xiao Wang; Xiao Zhang; Xiao Wang; Yang Xia; Gang-Jun Zong
Journal:  Biomed Rep       Date:  2016-09-26

2.  Vitamin D receptor gene polymorphisms and plasma renin activity in essential hypertensive individuals.

Authors:  S Cottone; L Guarino; R Arsena; C Scazzone; F Tornese; M Guarneri; C Guglielmo; A Bono; G Mulè
Journal:  J Hum Hypertens       Date:  2014-12-11       Impact factor: 3.012

Review 3.  Novel Approaches to Investigate One-Carbon Metabolism and Related B-Vitamins in Blood Pressure.

Authors:  Amy McMahon; Helene McNulty; Catherine F Hughes; J J Strain; Mary Ward
Journal:  Nutrients       Date:  2016-11-11       Impact factor: 5.717

4.  Effect of vitamin D supplementation versus placebo on essential hypertension in patients with vitamin D deficiency: a double-blind randomized clinical trial.

Authors:  Vida Sheikh; Azadeh Mozaianimonfared; Mohsen Gharakhani; Jalal Poorolajal
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-20       Impact factor: 3.738

5.  Sphingomyelin levels in nondipper and dipper hypertensive patients.

Authors:  Huan Zheng; Xiaoyun Xie; Nanzi Xie; Huifeng Xu; Junling Huang; Ming Luo
Journal:  Exp Ther Med       Date:  2013-12-19       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.